Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cells
Transfusion2020Vol. 60(10), pp. 2389–2398
Citations Over TimeTop 24% of 2020 papers
Christof Geisen, Anne North, Lisa Becker, V. Brixner, Melissa von Goetz, Laurence Corash, Richard J. Benjamin, Nina Mufti, Erhard Seifried
Abstract
Standardized RRC screening panels are sensitive for the detection of natural and acquired S-303-specific antibodies. Natural low titer antibodies to amustaline/GSH RBC are present in 0.15% of naïve patients. The clinical relevance of these antibodies appears minimal but is under further investigation.
Related Papers
- → Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2‐Butoxyethanol: II. Resistance in red blood cells from humans with potential susceptibility(1994)34 cited
- → In Vitro Sub-Hemolytic Effects of Butoxyacetic Acid on Human and Rat Erythrocytes(2002)43 cited
- → Effects of diethylene glycol butyl ether and butoxyethoxyacetic acid on rat and human erythrocytes(2004)21 cited
- → Limiting the Extent of a Delayed Hemolytic Transfusion Reaction With Automated Red Blood Cell Exchange(2013)20 cited